News Releases | Olink Holding AB

Date	Title
May 12, 2022	Olink reports first quarter 2022 financial results
May 09, 2022	University of Oxford adopts Olink technology to advance protein biomarker discovery and unravel mechanisms of disease
Apr 21, 2022	Olink to report first quarter 2022 financial results on May 12, 2022
Apr 07, 2022	Report from the Annual General Meeting of Olink Holding AB (publ) on 7 April 2022
Mar 17, 2022	Olink publishes 2021 annual report
Mar 09, 2022	TATAA Biocenter partners with Olink to add high quality proteomics with unrivaled throughput to their multi-omics offering
Mar 07, 2022	Notice to attend the Annual General Meeting of Olink Holding AB (publ)
Mar 07, 2022	THE NOMINATION COMMITTEE’S PROPOSAL FOR ELECTION OF MEMBERS OF THE BOARD OF DIRECTORS OF OLINK HOLDING AB (PUBL)
Feb 14, 2022	Olink reports fourth quarter and full year 2021 financial results and provides outlook for 2022
Feb 01, 2022	Olink to present at February investor conferences
Jan 20, 2022	Sequanta selects Olink® Explore 3072 to analyze new cohort study in China
Jan 10, 2022	Olink announces preliminary unaudited revenue for the fourth quarter and full year 2021
Jan 04, 2022	Olink to present at the 40th Annual J.P. Morgan Healthcare Conference
Dec 06, 2021	Innovation and transparency at the heart of Olink’s culture – details of the technology behind the Olink Explore high-throughput proteomics platform published in the journal, Molecular & Cellular Proteomics
Dec 02, 2021	Olink participates in one of the largest proteomics studies enabling new treatment options for patients with heart failure
Dec 01, 2021	Olink® Explore 3072 high-throughput proteomics platform now available: Significantly expands Olink's protein library for biomarker discovery
Nov 29, 2021	Melissa Amrein, at the University Hospital of Basel, Switzerland, is awarded the 2021 Novelties in Biomarkers prize at the Biomarkers of the Future Conference in Paris, France
Nov 23, 2021	Olink® Signature Q100 now available: A user friendly desktop instrument to broaden access to Olink’s multiplex protein analysis platform
Nov 11, 2021	Psomagen, Inc. is partnering with Olink Proteomics, enabling unprecedented multi-omics clinical studies
Nov 10, 2021	Olink reports third quarter 2021 financial results